Stock Hero Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs > Amarin Corp. PLC ADS (AMRN)

Leerink's biotech analyst holds an analyst/industry conference call

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
krunchtimepicks Member Profile
 
Followed By 9
Posts 1,475
Boards Moderated 0
Alias Born 03/05/06
160x600 placeholder
Advertisement
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 4/24/2015 6:47:35 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/24/2015 5:02:13 PM
Securities Registration (ads, Delayed) (f-6) "Edgar (US Regulatory)" - 4/22/2015 5:17:18 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 4/9/2015 4:12:58 PM
Healthcare stock screen of the month: Price extended, poor fundamentals "Seeking Alpha" - 4/8/2015 1:05:46 PM
Here's the Lowdown on Amarin Corporation PLCs 55% Move Higher in March "The Motley Fool" - 4/7/2015 9:19:13 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 4/3/2015 4:17:29 PM
3 Biotech Stocks in Danger of Running Out of Cash "The Motley Fool" - 4/2/2015 12:45:45 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/30/2015 4:32:49 PM
Should Investors Toss in the Towel on Amarin Corp Plc? "The Motley Fool" - 3/26/2015 12:02:02 PM
Shake Shack Shares Persist On The Hard To Borrow List "Seeking Alpha" - 3/24/2015 2:57:13 AM
Biotech Stocks: 2 to Avoid, 1 to Buy "The Motley Fool" - 3/22/2015 12:56:03 PM
Amarin's Case Vs. FDA Will Garner Positive Attention "Seeking Alpha" - 3/20/2015 5:44:35 PM
Amarin Argues In Court For Vascepa Exclusivity "Seeking Alpha" - 3/18/2015 8:39:01 PM
Why Amarin Corporation Plc Burst Today "The Motley Fool" - 3/17/2015 12:33:13 PM
Borrow Costs Elevated On CorMedix "Seeking Alpha" - 3/17/2015 3:09:22 AM
Premarket Gainers / Losers as of 9:10 am "Seeking Alpha" - 3/16/2015 9:14:04 AM
Amarin up premarket "Seeking Alpha" - 3/16/2015 8:41:53 AM
Amarin up premarket "Seeking Alpha" - 3/12/2015 8:27:09 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/11/2015 8:02:20 AM
Market Shrugs Off Amarin's New Financing "Seeking Alpha" - 3/9/2015 11:03:23 PM
Amarin secures $52.8M in new capital "Seeking Alpha" - 3/6/2015 7:16:57 AM
Amarin: Modeling Its Cash Balance Trajectory To 2017 "Seeking Alpha" - 3/5/2015 8:28:29 AM
Amarin's (AMRN) CEO John Thero on Q4 2014 Results - Earnings Call Transcript "Seeking Alpha" - 3/3/2015 8:46:05 PM
krunchtimepicks   Wednesday, 03/09/11 04:25:47 PM
Re: None
Post # of 48240 
Leerink's biotech analyst holds an analyst/industry conference call
Biotech Analyst Schwartz discusses prospects for Amarin's AMR-101 in the treatment of mixed Dyslipidemia: previewing the ANCHOR Study on an Analyst/Industry conference call being held on March 10 at 11 am hosted by Leerink.

www.theflyonthewall.com/.../AMRNid1391681/AMRN-Leerinks-biotech-analyst-holds-an-analystindustry-conference-call

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist